Eli Lilly is paying $100 million upfront for the right to develop CSL’s phase 3-stage IL-6 antibody that had previously been ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) to advance human cellular models of neurodegenerative ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks. Novartis is shelling out $100 ...

The FDA has accepted Moderna’s revised influenza vaccine filing days after controversially refusing to review the original submission, putting the biotech on track to win approval in time for the 2026 ...

Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. | Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling ...

Rasayana Therapeutics, a biotech targeting the gut’s connection to other organs, has slotted a new microbiome-boosting drug candidate into its pipeline. | In a deal with Theriva Biologics potentially ...

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.

A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. | A new entrant in the race to shepherd antibodies for Alzheimer’s disease across ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the ...

Preclinical CRO RoukenBio has inked a partnership with Connecticut-based biologics discovery specialist AVS Bio that aims to ...